Skip to main content
Premium Trial:

Request an Annual Quote

European Consortium, Including DeCode, Wins EUR8.1M to Study Genetics of Addiction

NEW YORK, Jan. 18 (GenomeWeb News) - A consortium of eight European research organizations, including DeCode Genetics of Iceland, has won an €8.1 million ($10.6 million) contract from the European Union to study the genetics of addiction, the UK's University of Surrey said yesterday.

 

The project, headed  by Ian Kitchen at the Universityof Surrey, will combine human population genetics with animal genetics and gene expression studies to identify genes involved in addiction. DeCode will head the human genetics component, working with Iceland's National Center of Addiction Medicine.

 

Funded through the EU's Sixth Framework Program, the initiative also includes researchers from the Universitat Pompeu Fabra in Barcelona, Spain; Universite Louis Pasteur in Strasbourg, France; Life and Brain in Bonn, Germany; the PolishAcademyof Sciences in Krakow, Poland; and the HungarianAcademyof Sciences in Budapest, Hungary.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.